Xyzal FDA Approval History
FDA Approved: Yes (First approved May 25, 2007)
Brand name: Xyzal
Generic name: levocetirizine dihydrochloride
Company: UCB, Inc. and sanofi-aventis
Treatment for: Allergic Rhinitis, Allergic Urticaria
Xyzal (levocetirizine) is an antihistamine for the relief of symptoms associated with allergic rhinitis and urticaria.
Development timeline for Xyzal
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.